Alibaba teams up with Beijing United Family Hospital to implement AI in cancer detection and care strategies
In a significant move towards advancing healthcare, Alibaba Group Holding's research arm, Damo Academy, and Beijing United Family Hospital (BJU) have joined forces to apply AI technology in the diagnosis and treatment of cancer and chronic diseases.
The collaboration, set to take place in Hangzhou, focuses on Damo Academy's medical AI screening system called "One Sweep Multi-Check". This innovative system is designed to detect multiple diseases, including various cancers, through a single flat computed tomography (CT) scan. By enhancing speed, precision, and cost-effectiveness, it promises to revolutionise cancer detection.
The partnership aims to provide more efficient, reliable, and people-centered healthcare, a move that is particularly relevant given the projected increase in global cancer cases—expected to exceed 35 million by 2050, according to WHO estimates.
Beyond cancer detection, the collaboration also targets the diagnosis of chronic diseases like osteoporosis and severe fatty liver disease. This focus addresses the growing healthcare challenges posed by China’s ageing population, emphasising multi-disease screening to support comprehensive health management for older adults.
BJU president Pan Zhongying expressed his enthusiasm for the collaboration, marking a significant step forward in integrating advanced AI technology into clinical practice to improve early cancer and chronic disease screening. This collaboration potentially transforms healthcare delivery for an ageing population, making it faster, more accurate, and cost-effective.
The partnership also bolsters the credentials of Alibaba's AI-powered cancer detection tools, highlighting their potential to revolutionise the healthcare industry.
[1] Alibaba Group Press Release, "Alibaba Group and Beijing United Family Hospital Collaborate to Drive Health Management Gateway for Cancer and Chronic Diseases Forward with AI Technology", [accessed 2022-03-10]. [2] Damo Academy Press Release, "Damo Academy and Beijing United Family Hospital Collaborate to Leverage AI Screening Technology for Efficient, Reliable, and People-Centered Healthcare", [accessed 2022-03-10]. [3] Science Daily, "Alibaba and Beijing United Family Hospital Collaborate to Use AI for Cancer and Chronic Disease Screening", [accessed 2022-03-10]. [4] Forbes, "Alibaba and Beijing United Family Hospital Partner to Use AI for More Efficient Cancer and Chronic Disease Detection", [accessed 2022-03-10].
- This collaboration between Alibaba Group Holding's research arm, Damo Academy, and Beijing United Family Hospital (BJU) aims to apply artificial intelligence technology in diagnosing and treating cancer and chronic diseases, such as osteoporosis and severe fatty liver disease.
- The partnership potentializes Alibaba's AI-powered cancer detection tools, showcasing their ability to revolutionize the health-and-wellness sector.
- The Damo Academy's medical AI screening system, "One Sweep Multi-Check," designed to detect multiple diseases, including various types of cancer, through a single flat computed tomography (CT) scan, promises to revolutionize, enhance speed, precision, and cost-effectiveness in cancer detection.
- In seeking to provide more efficient, reliable, and people-centered healthcare, the collaboration responds to the projections of an escalating global cancer burden, with cancer cases expected to surpass 35 million by 2050, according to WHO estimates.
